SelectQuote, Inc.: Form 10-Q for the period ended Mar 31, 2023
Filed with the SEC on May 10, 2023 and accepted by EDGAR at May 10, 2023, 16:33 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2023-03-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2023-01-01 to 2023-03-31 | $299.4m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 9 months2022-07-01 to 2023-03-31 | $781.1m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Selling, general and administrative | 3 months2023-01-01 to 2023-03-31 | $27.5m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months2022-07-01 to 2023-03-31 | $86.7m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2023-01-01 to 2023-03-31 | $33.7m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2022-07-01 to 2023-03-31 | $47.2m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2023-01-01 to 2023-03-31 | $21.1m | us-gaap:InterestExpense |
| Interest expense | 9 months2022-07-01 to 2023-03-31 | $58.9m | us-gaap:InterestExpense |
| Income tax | 3 months2023-01-01 to 2023-03-31 | $3.2m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2022-07-01 to 2023-03-31 | −$1.1m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2023-01-01 to 2023-03-31 | $9.3m | us-gaap:NetIncomeLoss |
| Net income | 9 months2022-07-01 to 2023-03-31 | −$10.7m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2023-01-01 to 2023-03-31 | $0.06 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2022-07-01 to 2023-03-31 | −$0.06 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2023-01-01 to 2023-03-31 | $0.06 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2022-07-01 to 2023-03-31 | −$0.06 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2023-01-01 to 2023-03-31 | 167,905,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2022-07-01 to 2023-03-31 | 165,951,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2022-07-01 to 2023-03-31 | −$12.8m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2022-07-01 to 2023-03-31 | $1.1m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2023-03-31 | $92.0m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2023-03-31 | $383.8m | us-gaap:AssetsCurrent |
| Total assets | At period end2023-03-31 | $1.29bn | us-gaap:Assets |
| Current liabilities | At period end2023-03-31 | $146.5m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2023-03-31 | $896.5m | us-gaap:Liabilities |
| Long-term debt | At period end2023-03-31 | $667.3m | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2023-03-31 | $25.4m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | At period end2023-03-31 | $391.4m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001794783-23-000049. Last ingested by Listed: Nov 4, 2026, 09:23 ET. Listed shows no prices and gives no investment advice.